Drugs / DLI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07254793 | Oct 2026 → Jun 2030 expected | acute lymphoblastic leukemia, acute undifferentiated leukemia, chronic myeloid leukemia, myelodysplastic syndrome | University of Arizona | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DLI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07254793 ↗ |